Related Experiment Video

Updated: May 12, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Biomarkers of cardiovascular risk in sleep-deprived people

M A Miller1, F P Cappuccio

  • 1Warwick Medical School, University of Warwick, Coventry, UK.

Journal of Human Hypertension
|April 19, 2013
PubMed

Insights

Short sleep duration is an emerging risk factor for cardiovascular diseases (CVD), including stroke and coronary heart disease (CHD). Understanding sleep

Area of Science:

  • Cardiovascular Medicine
  • Sleep Science
  • Metabolic Health

Background:

  • Global increases in coronary heart disease (CHD) and cardiovascular disease (CVD) necessitate improved risk prediction beyond traditional factors.
  • Existing risk prediction models often fail to identify all individuals at risk.
  • Emerging research suggests novel risk factors, including those related to endothelial function, inflammation, and oxidative stress, offer limited improvements in risk classification.

Purpose of the Study:

  • To examine the evidence linking short sleep duration to obesity, type 2 diabetes, hypertension, stroke, CHD, and CVD.
  • To investigate the underlying mechanisms by which short sleep may influence established cardiovascular risk factors.
  • To assess the potential of sleep-modulated biomarkers for predicting cardiovascular risk and informing disease management.

Main Methods:

  • Review of emerging scientific literature on short sleep duration and its association with metabolic and cardiovascular outcomes.
  • Analysis of proposed physiological pathways linking short sleep to obesity, diabetes, hypertension, and thrombosis.
  • Evaluation of the predictive value of biomarkers affected by sleep duration for cardiovascular disease risk.

Main Results:

  • Short sleep duration is identified as a potential independent risk factor for obesity, type 2 diabetes, hypertension, stroke, CHD, and CVD.
  • Short sleep may modulate the relationship between established cardiovascular risk factors and disease development.
  • Biomarkers related to appetite control, metabolism, glucose homeostasis, inflammation, and hemostasis are affected by sleep duration and may serve as predictors.

Conclusions:

  • Short sleep duration represents a significant, modifiable risk factor for cardiovascular diseases.
  • Further research into sleep-modulated biomarkers could enhance cardiovascular disease risk prediction, detection, and prevention strategies.
  • Integrating sleep assessment into clinical practice may improve management of individuals at risk for cardiovascular events.

More Related Videos

Establishing a Device for Sleep Deprivation in Mice05:05

Establishing a Device for Sleep Deprivation in Mice

Published on: September 22, 2023

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Concept Videos

Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...